• Final summary

    What an amazing three days I’ve had in Hong Kong at the APACC 2018 conference, learning about the current thinking in prevention, treatment and future of HIV and co-infections in the Asia Pacific region. I’m very thankful to ASHM for awarding me a scholarship to attend the conference, which has given me so much to take back to Melbourne to discuss. Although my first-time blogging attempts may not completely reflect it, we heard and learned from some very passionate and forward thinking speakers who presented their research in HIV and Hepatitis.

  • Viral Hepatitis Hep C: How are We Going to Get to Hep C Elimination From A Clinicians Perspective

    A/Prof Gail Matthews,  Kirby Institute, UNSW, Australia

    Elimination is reduction in incidence and related mortality to a level that are no longer a public health concern. A/Prof Matthews describes a number of ways in which clinicians can and do contribute directly to this aim. According to A/Prof Kirby, 9 countries are on track to meet targets, Australia is lucky to be one of them. She identified an increasing prescriber base with no need for specialists in most cases. 

  • Access and Elimination of HIV

    Panel Discussion

     As a conclusion to the APACC 2018 conference, this discussion was a fantastic example of the learning that can happen when clinicians, researchers, advocates and PLHIV come together and share their work and ideas. 

  • Key Populations-Led Health Service (KPLHS) Models  Chairs: Nittaya Phanuphak & Jeremy Ross

    Why we need KPLHS to end AIDS in the Asia Pacific

    Michael Cassell FHI 360 Thailand 

  • The 4th 90 Quality of life: Ageing with HIV in Asia and the Pacific 

    Speakers:

    Presented by Jessica Michaels and Scott McGill, ASHM  Symposium with Panel

    Dr Grace Liu, HIV Metabolic Clinic , Prince of Wales Hospital, Hong Kong

    Dr Gary Lee, GP, Holdsworth House, Sydney Australia

    Dr Evy Yunihastuti, University of Indonesia

  • Social Media and mHealth 

    I am aware of some social media and mHealth interventions being implemented in Australia, but I had no idea of the enormity of the potential impact, and the range of ways in which these technologies can be used for HIV prevention, management, and improvement in quality of life for people who are HIV positive. It was mind-blowing to hear from one of the presenters that more than 1 billion people are active social media users, and how that reach can be optimised for the benefit of those at risk of or diagnosed with HIV. I found this fascinating, as like many clinicians, I have imagined social media to be helpful, but no idea how it can be harnessed, or whether there is actual evidence for its efficacy.

  • Public health approach to reduce the burden of advanced HIV disease 

    By Polin Chan, WHO

     

    Polin’s presentation was an important insight into the development of guidelines in general – why they are important, what is included in them, and why we can trust them to direct our clinical practice.

  • The management of the HIV patient: Where have we been, where are we now, where do we need to go?

    Jose Gatell, Senior Medical Director ViiV Healthcare University of Barcelona, Spain

     

    Jose Gatell’s presentation on the history, current status and future of managing HIV positive patients was a fascinating insight into how far we’ve come, and how far we have to go. Luckily, with an engaging and interactive presentation, he gives us hope that we’ll get there!

  • CHEMSEX

    Carol Khaw’s presentation on the first Australian study of Chemsex was a crucial step in understanding this important issue in this region. Most of our existing knowledge is based on UK research, and it is yet to be taken further in Australia. Based in South Australia, this important clinic based questionnaire study aimed to determine:

    • Prevalence of Chemsex among men who have sex with men (MSM)
    • The characteristics and risk profiles of the group of MSM who engage in Chemsex
    • Any associations between Chemsex and STIs, including HIV diagnosis in MSM

     

  • Reflections from the Professor David Cooper memorial lecture

    It was an inspiring start to the 2018 APACC conference, with the first session foreshadowing conference highlights, and paying tribute to Professor David Cooper, who contributed so enormously to the field and the APACC conference itself.